Grace Lu-Yao, PhD, MPH

Grace Lu-Yao, PhD, MPH

Contact Dr. Lu-Yao

233 S. 10th Street
Philadelphia, PA 19107

(215)
(215) fax

Most Recent Peer-reviewed Publications

  1. Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017
  2. Differential and Joint effects of metformin and statins on overall survival of elderly patients with pancreatic adenocarcinoma: A large population-based study
  3. Validation of a Contemporary Five-tiered Gleason Grade Grouping Using Population-based Data
  4. Does Certificate of Need Minimize Intensity Modulated Radiation Therapy Use in Patients with Low Risk Prostate Cancer?
  5. Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Grace L. Lu-Yao, Peter C. Albertsen, Dirk F. Moore, Yong Lin, Robert S. DiPaola, Siu-Long Yao. Fifteen-year Outcomes Following Conservative Management among Men Aged 65 Years or Older with Localized Prostate Cancer. Eur Urol 2015;68:805-11
  6. Primary radiotherapy vs conservative management for localized prostate cancer - A population-based study
  7. Fifteen-year outcomes following conservative management among men aged 65 years or older with localized prostate cancer
  8. Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: Results of a population-based, propensity score-matched analysis
  9. Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer
  10. Metabolic dysregulation of the insulin-glucose axis and risk of obesity-related cancers in the Framingham heart study-offspring cohort (1971-2008)
  11. Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications
  12. Re: Radical prostatectomy versus observation for localized prostate cancer
  13. In regard to Shen et al
  14. Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last?
  15. Reply from authors re: Karim Fizazi. Who should receive Androgen deprivation therapy? Eur Urol 2012;62:973-4: Overcoming patient selection bias in observational studies
  16. Does primary androgen-deprivation therapy delay the receipt of secondary cancer therapy for localized prostate cancer?
  17. Longitudinal associations of leisure-time physical activity and cancer mortality in the Third National Health and Nutrition Examination Survey (1986-2006)
  18. Reply to Carl J. Rossi, Jr.'s Letter to the editor re: Sung Kim, Shunhua Shen, Dirk F. Moore, et al. Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur Urol 2011;60:908-16
  19. The impact of PSA testing frequency on prostate cancer incidence and treatment in older men
  20. Treatment profile and complications associated with cryotherapy for localized prostate cancer: A population-based study